1. Home
  2. ATCH vs NMTC Comparison

ATCH vs NMTC Comparison

Compare ATCH & NMTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AtlasClear Holdings Inc.

ATCH

AtlasClear Holdings Inc.

HOLD

Current Price

$0.22

Market Cap

40.1M

Sector

N/A

ML Signal

HOLD

Logo NeuroOne Medical Technologies Corporation

NMTC

NeuroOne Medical Technologies Corporation

HOLD

Current Price

$4.28

Market Cap

39.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATCH
NMTC
Founded
2022
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
40.1M
39.5M
IPO Year
2024
2010

Fundamental Metrics

Financial Performance
Metric
ATCH
NMTC
Price
$0.22
$4.28
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$1.00
$11.90
AVG Volume (30 Days)
3.0M
44.8K
Earning Date
05-15-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
80.43
EPS
0.05
N/A
Revenue
N/A
$9,097,692.00
Revenue This Year
$84.47
N/A
Revenue Next Year
$39.32
$31.90
P/E Ratio
$4.70
N/A
Revenue Growth
N/A
163.47
52 Week Low
$0.14
$0.55
52 Week High
$1.92
$5.40

Technical Indicators

Market Signals
Indicator
ATCH
NMTC
Relative Strength Index (RSI) 35.18 61.26
Support Level $0.21 $0.69
Resistance Level $0.24 $4.87
Average True Range (ATR) 0.02 0.31
MACD -0.01 -0.15
Stochastic Oscillator 2.28 35.79

Price Performance

Historical Comparison
ATCH
NMTC

About ATCH AtlasClear Holdings Inc.

AtlasClear Holdings Inc is a fintech company. Its goal is to build a cutting-edge technology-enabled financial services firm that would create a more efficient platform for trading, clearing, settlement, and banking of evolving and financial products with a focus on financial services firms. It is a fintech-driven business-to-business platform that expects to power innovation in fintech, investing, and trading. The company believes it is positioned to provide a modern, mission-critical suite of solutions to its clients, enabling them to reduce their transaction costs and compete more effectively in their businesses.

About NMTC NeuroOne Medical Technologies Corporation

NeuroOne Medical Technologies Corp is focused on diagnostic, ablation, and deep brain stimulation technology for brain-related conditions such as epilepsy and Parkinson's disease; ablation and stimulation for pain management; and drug delivery with diagnostic and stimulation capabilities. It develops thin film electrode technology for various recording and therapeutic applications, crucial for diagnosing neurological disorders such as epilepsy, Parkinson's disease, dystonia, and essential tremors. The company operates in one segment, developing and commercializing products for neuromodulation, cEEG, and sEEG recording, monitoring, ablation, and brain stimulation, with revenue from Evo Cortical, Evo sEEG, and OneRF Ablation System.

Share on Social Networks: